RxConnection | Newsletter

Home > Newsletter (Page 3)

April 4 RxAdvocate April, 2023 — Newsletter

Posted at 12:36h in Newsletter

0 Likes

COVID Update Drug Shortages OTC Narcan Announcements...

Posted at 14:44h in Newsletter

0 Likes

New Hemophilia A Drug RSV Vaccine Wegovy and Ozempic Insulin Prices...

Posted at 14:11h in Newsletter

0 Likes

Humira Biosimilar Mounjaro Marketing New Cancer Drugs Approval...

Posted at 13:58h in Newsletter

0 Likes

Cervical Cancer Awareness Alzheimer's Treatment 5 Questions Facing the Pharmaceutical Industry...

Posted at 13:35h in Newsletter

0 Likes

FDA Approves new Hemophilia B Drug US Drug Supplies Tripledemic Annual Leadership Onsite...

Posted at 21:14h in Newsletter

0 Likes

Opiod Epidemic Lawsuits Overdose Reversal OTC New Discount Card Partnership...

Posted at 20:56h in Newsletter

0 Likes

Malaria Vaccine Botox Rival Revance Gets U.S. Approval COVID-19 Vaccine Boosters Organizational Announcement Team Community Involvement ...

Posted at 20:40h in Newsletter

0 Likes

Malaria Vaccine Botox Rival Revance Gets U.S. Approval COVID-19 Vaccine Boosters Organizational Announcement Team Community Involvement ...

Posted at 20:08h in Newsletter

0 Likes

Dobbs v. Jackson FDA Vitiligo Therapy Consolidated Appropriations Act ...

Posted at 19:27h in Newsletter

0 Likes

UV Safety Month Omnipod Coverage Sildenafil Recognized as Candidate for Alzheimer's RxConnection Team Involvement...